As a neurologist, I’ve always been driven by an evidence-based approach to medicine, but as a woman, I’m deeply attuned to the realities of cyclical health. Lately, both in my clinical practice and within our Two Moons community, I’ve noticed a wave of confusion. With wellness content exploding around Mast Cell Activation Syndrome (MCAS) and histamine 'buckets,' many are left wondering if histamine is the hidden culprit behind their severe PMS.
Let’s look at what the research actually says about how our reproductive hormones interact with histamine biology.
The Biological Cross-Talk: Hormones Meet Histamine
For many women, the days leading up to a period can feel like a perfect storm of physical and emotional symptoms. As interest grows in the role of histamine, mast cells, and inflammation in women's health, some have begun to wonder whether Premenstrual Syndrome (PMS) and Premenstrual Dysphoric Disorder (PMDD) may actually be driven by histamine intolerance or mast cell activation.
While emerging research shows a fascinating connection between reproductive hormones and histamine biology, the current evidence does not support histamine dysregulation as a primary cause of PMS or PMDD. Instead, PMS and PMDD remain distinct cyclical disorders linked to an increased sensitivity to normal fluctuations in estrogen and progesterone, particularly through effects on serotonin and the calming neurosteroid allopregnanolone.
Histamine, however, may influence symptom severity in some women because estrogen can stimulate mast cells to release histamine, while progesterone appears to have a stabilizing effect. This hormonal interplay means that histamine-related symptoms may fluctuate throughout the menstrual cycle, especially around ovulation and in the days before menstruation.
Decoding: Is it PMS or Histamine Intolerance?
Understanding the different symptom presentations is key. PMS and PMDD are characterized by symptoms that emerge during the luteal phase - the two weeks before menstruation - and resolve during or shortly after the period begins, followed by a symptom-free interval.
PMDD represents the more severe end of the spectrum and includes prominent mood symptoms such as irritability, anxiety, depression, or emotional lability. In contrast, Histamine Intolerance (HIT) and Mast Cell Activation Syndrome (MCAS) typically produce symptoms throughout the month, although these symptoms may worsen premenstrually. Common manifestations include headaches, flushing, hives, itching, nasal congestion, gastrointestinal upset, palpitations, sleep disruption, and anxiety.
Because many of these symptoms overlap with PMS, distinguishing between the two can be challenging. A useful clinical clue is that histamine-related symptoms are often triggered or aggravated by histamine-rich foods, alcohol, or environmental exposures, whereas PMS symptoms are driven by the menstrual cycle itself and are not typically linked to specific dietary triggers.
Unpacking Premenstrual Exacerbation (PME)
When a chronic condition such as HIT, MCAS, migraine, asthma, allergies, or a mood disorder worsens before a period but remains present throughout the cycle, this is classified as Premenstrual Exacerbation (PME) rather than true PMS or PMDD.
The relationship becomes even more intriguing during perimenopause, when estrogen levels can fluctuate dramatically and unpredictably. These hormonal swings may theoretically provoke greater mast cell activation in susceptible women, potentially contributing to symptoms such as flushing, headaches, insomnia, anxiety, or worsening allergies.
Treatment Implications and the Clinical Reality
However, despite growing interest in this area, there are currently no robust clinical studies demonstrating that histamine dysregulation is a primary driver of PMS, PMDD, or perimenopausal symptoms.
This distinction has important treatment implications. While low-histamine diets, Diamine Oxidase (DAO) supplementation, mast cell stabilizers, or antihistamines may be beneficial for women with confirmed histamine intolerance or mast cell activation disorders, they should not be considered standalone treatments for PMS or PMDD.
Because true PMS stems from cyclical hormonal shifts, we formulated our Two Moons seed cycling capsules to align with your follicular and luteal phases, for alleviation with natural, plant-based ingredients.
Histamine-directed therapies may have a role in selected women whose symptoms reflect an underlying histamine-related condition, but current evidence does not support antihistamines as a primary or universal treatment for PMS itself.
The bottom line: histamine is not currently recognized as a primary driver of PMS or PMDD in major guidelines (ACOG, DSM-5), but the estrogen-mast cell-histamine axis provides a plausible mechanism for premenstrual exacerbation of histamine-mediated symptoms in susceptible individuals.
Prospective clinical studies directly measuring histamine and DAO activity across the menstrual cycle and perimenopause in symptomatic women are lacking. As research continues to explore the intricate interplay between reproductive hormones, mast cells, and histamine signaling, a clearer understanding of these relationships may ultimately lead to more personalized and effective approaches to managing hormone-related symptoms across a woman’s cycle span and lifespan.
While this blog discusses health topics, it is not a substitute for professional medical advice. Always consult your doctor or other qualified healthcare provider regarding any question you might have regarding your health.
About the Author
Dr. Ulrike Kaunzner is a neurologist with a focus on neuroimmunology who combines evidence-based care for women’s health with a commitment to integrative medicine. Trained in Germany, and France, and through her residency in NYC, she is passionate about lifelong learning and sharing her knowledge with her patients.